文献速递泌尿生殖与妇科肿瘤放疗

局限性前列腺癌雄激素剥夺治疗后的睾酮恢复:两项随机试验的长期数据

Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials.
PubMed 文献 · Radiother Oncol · 2024-03-27

在1230例接受放疗联合0、6、18或36个月雄激素剥夺治疗(ADT)的局限性前列腺癌患者中,睾酮恢复率随ADT时长增加而降低,恢复中位时间随ADT延长而增加,基线睾酮正常者恢复更快;年龄较大和ADT时长较长与较低睾酮恢复相关。

要点

  • 0、6、18、36个月ADT方案睾酮恢复正常比例分别为87.4%、75.9%、54.8%、43.2%(p<0.001)。
  • 恢复者中位恢复时间随ADT延长分别为0.31、1.64、3.06、5.0年(p<0.001)。
  • 基线睾酮正常者恢复显著更快(p<0.001),年龄较大和ADT较长与较低恢复相关。

核心结论

  • ADT后睾酮恢复率取决于激素时长、基线睾酮正常、年龄和内科合并症等因素,较长ADT时长是影响睾酮恢复的最重要变量。

研究设计与样本

  • 两项III期随机试验共纳入1230例局限性前列腺癌患者,接受放疗联合0、6、18或36个月ADT,基线及定期监测血清睾酮。

主要发现

  • 0、6、18、36个月ADT方案睾酮恢复正常比例分别为87.4%(167/191)、75.9%(293/386)、54.8%(181/330)、43.2%(80/185)(p<0.001)。
  • 恢复者中位恢复时间随ADT延长分别为0.31、1.64、3.06、5.0年(p<0.001),基线睾酮正常者恢复显著更快(p<0.001)。
  • 多因素分析显示年龄较大和ADT时长较长与较低睾酮恢复相关。

关键数值与推荐

  • 0、6、18、36个月ADT方案睾酮恢复率分别为87.4%、75.9%、54.8%、43.2%(p<0.001)。
  • 恢复者中位恢复时间分别为0.31、1.64、3.06、5.0年(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To determine the rate and time of testosterone (T) recovery in patients (pts) with localised prostate cancer treated with radiotherapy plus 0-, 6-, 18- or 36-month of androgen deprivation therapy (ADT). MATERIALS AND METHODS: In 1230 pts with prostate cancer randomised into two phase III trials, serum T was measured at baseline, then regularly. T recovery rate was compared between normal vs. abnormal baseline T and with ADT duration with Chi-square test or Fisher's exact test. A multivariable logistic regression model to predict the probability of recovering normal T was performed. RESULTS: Overall, 87.4 % (167/191), 75.9 % (293/386), 54.8 % (181/330) and 43.2 % (80/185) of pts, recovered normal T on the 0-, 6-, 18- or 36-month schedule, respectively (p < 0.001). In patients recovering normal T, the median time to T recovery increased with ADT duration ranging from 0.31, 1.64, 3.06 to 5.0 years for the 0-, 6-, 18- or 36-month schedules, respectively (p < 0.001) and was significantly faster for those with a normal T at baseline (p < 0.001). On multivariable analysis, older age and longer ADT duration are associated with a lower T recovery. CONCLUSIONS: Testosterone recovery rate after ADT depends on several factors including hormonal duration, normal baseline T, age and medical comorbidities. A longer ADT duration is the most important variable affecting T recovery. The data from this report might be a valuable tool to help physicians and patients in evaluating risks and benefits of ADT.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Nabid A, Carrier N, Vigneault E, et al. Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials. Radiother Oncol. 2024. PMID: 38552845. doi:10.1016/j.radonc.2024.110256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。